Latest current affairs · 22 Oct
Enrol · ₹3,500
Latest current affairs22 Oct
Free live webinar · NABARD Grade A 2026: 45-Day Final Revision Plan + Daily Targets · Sun, 25 Oct at 7:30 PM ISTJoin free
Skip to content

Tirzepatide: Obesity Drug

1 min read
All exams GA
In one line

Context:

Tirzepatide: Obesity Drug 1
Credit: The Hindu

US pharma giant Eli Lilly, which plans to bring its obesity and diabetes drug Tirzepatide (or Mounjaro) to India next year.

About the Drug:

  • Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin). 
  • It is sold under the brand names Mounjaro for diabetes treatment, and Zepbound for weight loss.

Drug Composition:

Tirzepatide is a linear polypeptide of 39 amino acids that has been chemically modified by lipidation to improve its uptake into cells and its stability to metabolism.

Eli Lilly:

Eli Lilly is a pharmaceutical company that was founded by Colonel Eli Lilly, a Union Army veteran and pharmaceutical chemist, in 1876.

Free · NABARD Grade A Want the free material for your exam?

ARD notes, the monthly current affairs PDF and a descriptive English sample — all free, on WhatsApp.

Only study material and course updates. No spam.

Related on Clarity 4 Sure

WhatsApp